$81 Mln Funding!!!
Entact Bio is a company pioneering the development of precision medicines that enhance the function of key proteins.
Entact Bio medicines enhance protein function by harnessing the power of enzymes called deubiquitinases, or DUBs, which are key regulators of proteins in the cell.
Entact Bio has raised $81 million funding round.
#funding #biotech #startup #ubiquitin #pathway #targetprotein #proteindegradation #precisionmedicine
#molecule #vc
#vc #molecule #precisionmedicine #proteindegradation #targetprotein #pathway #ubiquitin #startup #biotech #funding